Related content

GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study †

By Papanikolaou E.G.   Pados G.   Grimbizis G.   Bili E.   Kyriazi L.   Polyzos N.P.   Humaidan P.   Tournaye H.   Tarlatzis B.  

Human Reproduction, Vol. 27, Iss. 6, 2012-06 ,pp. : 1822-1828

Oxford University Press

Access to resources Recommend Favorite

GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

By Engmann Lawrence   Benadiva Claudio  

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3258-3260

Oxford University Press

Access to resources Recommend Favorite

GnRH agonist versus GnRH antagonist in oocyte donation cycles: a prospective randomized study

By Prapas N.  

Human Reproduction, Vol. 20, Iss. 6, 2005-06 ,pp. : 1516-1520

Oxford University Press

Access to resources Recommend Favorite

The combined GnRH-agonist and intrauterine levonorgestrel-releasing system treatment of complicated atypical hyperplasia and endometrial cancer: a pilot study

By Pashov Alexandr I.   Tskhay Vitaly B.   Ionouchene Svetlana V.  

Gynecological Endocrinology, Vol. 28, Iss. 7, 2012-07 ,pp. : 559-561

Informa Healthcare

Access to resources Recommend Favorite

GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

By Humaidan P.  

Human Reproduction, Vol. 20, Iss. 5, 2005-05 ,pp. : 1213-1220

Oxford University Press

Access to resources Recommend Favorite